School personnel information

写真b

NAITOU Youko


Organization 【 display / non-display

  • 2009.04.01 - 2011.03.31, Research Institute for Microbial Diseases, Specially Appointed Researcher

  • 2011.04.01 - 2013.03.31, Research Institute for Microbial Diseases, Specially Appointed Researcher

  • 2013.04.01 - 2014.03.31, Immunology Frontier Research Center, Specially Appointed Researcher

  • 2014.04.01 - 2016.03.31, Division of Medicine, Graduate School of Medicine, Specially Appointed Researcher

  • 2016.10.01 - 2017.03.31, Research Institute for Microbial Diseases, Specially Appointed Researcher

  • 2019.09.01 - , Immunology Frontier Research Center, Specially Appointed Researcher

 

Academic Papers 【 display / non-display

  • ELAS1 induces apoptotic death in adenocarcinoma DU145 and squamous-cell carcinoma SAS cancer cells, but not in normal KD cells., Uchihashi T, Ota K, Yabuno Y, Ohno S, Fukushima K, Naito Y, Kogo M, Yabuta N, Nojima H, Oncotarget,8(49) 85868-85882, 2017.10, Papers

  • GAK is phosphorylated by c-Src and translocated from the centrosome to chromatin at the end of telophase., Fukushima K, Wang M, Naito Y, Uchihashi T, Kato Y, Mukai S, Yabuta N, Nojima H, Cell Cycle,16(5) 1-13, 2017.03, Papers

  • ELAS1-mediated inhibition of the cyclin G1-B'γ interaction promotes cancer cell apoptosis via stabilization and activation of p53., Ohno S, Naito Y, Mukai S, Yabuta N, Nojima H., Oncogene,34(49) 5983-96, 2015.10, Papers